Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Minority Interest: 2022-2025

Historic Minority Interest for Gyre Therapeutics (GYRE) over the last 2 years, with Sep 2025 value amounting to $35.5 million.

  • Gyre Therapeutics' Minority Interest rose 0.57% to $35.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.5 million, marking a year-over-year increase of 0.57%. This contributed to the annual value of $35.1 million for FY2024, which is 17.82% up from last year.
  • According to the latest figures from Q3 2025, Gyre Therapeutics' Minority Interest is $35.5 million, which was down 5.14% from $37.4 million recorded in Q2 2025.
  • In the past 5 years, Gyre Therapeutics' Minority Interest ranged from a high of $37.4 million in Q2 2025 and a low of $29.7 million during Q4 2022.
  • Moreover, its 3-year median value for Minority Interest was $35.2 million (2024), whereas its average is $34.3 million.
  • Data for Gyre Therapeutics' Minority Interest shows a peak YoY climbed of 17.82% (in 2024) over the last 5 years.
  • Gyre Therapeutics' Minority Interest (Quarterly) stood at $29.7 million in 2022, then increased by 0.28% to $29.8 million in 2023, then rose by 17.82% to $35.1 million in 2024, then grew by 0.57% to $35.5 million in 2025.
  • Its last three reported values are $35.5 million in Q3 2025, $37.4 million for Q2 2025, and $36.2 million during Q1 2025.